SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
Learn more Accenture has invested, through Accenture Ventures, in Iridius, an enterprise AI infrastructure company that ...
Washington’s life sciences industry has outpaced national life science and state private-sector job growth for the fifth ...
Women and nonwhite racial/ethnic groups are still earning less in the life sciences. An industry consultant discusses the pay ...
Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...
Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit ...
Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The life sciences sector, spanning biotech, pharmaceuticals ...
W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...
Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio ...
It's the final day to submit your nominees for this year's Fiercest Women in Life Sciences! The nomination form will close at 11:59 p.m. ET on Friday, Sept. 26. Every year, we celebrate women making a ...
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results